Imperial College London

ProfessorAnneLingford-Hughes

Faculty of MedicineDepartment of Medicine

Chair in Addiction Biology
 
 
 
//

Contact

 

+44 (0)20 7594 8682anne.lingford-hughes Website

 
 
//

Assistant

 

Miss Sheila McKenzie +44 (0)20 7594 7047

 
//

Location

 

Burlington DanesHammersmith Campus

//

Summary

 

Summary

Professor Anne Lingford-Hughes is Head, Centre for Psychiatry and Professor of Addiction Biology at Imperial College London. She is also a Consultant Psychiatrist with a particular interest in pharmacological treatments of alcohol problems and other substance addictions at Central North West London NHS Foundation Trust. Her research has focused on using neuroimaging and neuropharmacological challenges to characterize the neurobiology of addiction. In particular she has used positron emission tomography (PET) and MR to characterize the dopamine (DRD2, DRD3), opioid (mu), GABA-benzodiazepine (a5 subtype), GABA-B, NK1 receptor systems in a range of substance addictions including alcoholism, cocaine and opiate dependence as well disordered gambling. More recently she has been exploring neuroinflammatory processes and amyloid deposition in alcoholism. The aim of her research programme is to better understand neurobiology underpinning these disorders to improve treatment.

If you are interested in finding out more about our studies into alcoholism and participating if you are abstinent and well, please email cfn.recruitment@imperial.ac.uk for more information.

Professor Anne Lingford-Hughes leads the MRC Addiction Research Clinical Training Programme (MARC) with Prof Colin Drummond, IOPPN, KCL and Prof Matt Hickman, University of Bristol. For events and opportunities associated with MARC see https://www.imperial.ac.uk/medicine/study/mrc-addiction-research-clinical-training/. Please contact us if you are a clinician interested in exploring the possibility of conducting a PhD in the area of addiction to develop your career in this vital clinical area.

Prof Lingford-Hughes is past Hon. General Secretary of the British Association for Psychopharmacology. She co-developed and wrote their guidelines about the pharmacological management of substance misuse and addiction and comorbidity with psychiatric disorders. She has also contributed to NICE guidance regarding pharmacotherapy of opiate detoxification and alcohol misuse and dependence.

She is currently Chair of the Academic Faculty of RCPsych.

She graduated in medicine from Oxford University, completed her PhD at Cambridge University, and trained in psychiatry at The Bethlem and Maudsley Hospitals and Institute of Psychiatry.

Publications

Journals

Limbrick-Oldfield EH, Mick I, Cocks RE, et al., 2017, Neural substrates of cue reactivity and craving in gambling disorder., Transl Psychiatry, Vol:7

McGonigle J, Murphy A, Paterson LM, et al., 2017, The ICCAM platform study: An experimental medicine platform for evaluating new drugs for relapse prevention in addiction. Part B: fMRI description., J Psychopharmacol, Vol:31, Pages:3-16

Quelch DR, Mick I, McGonigle J, et al., 2017, Nalmefene Reduces Reward Anticipation in Alcohol Dependence - An Experimental fMRI Study, Biological Psychiatry, ISSN:0006-3223

Cooper SJ, Reynolds GP, Barnes TRE, et al., 2016, BAP guidelines on the management of weight gain, metabolic disturbances and cardiovascular risk associated with psychosis and antipsychotic drug treatment, Journal of Psychopharmacology, Vol:30, ISSN:0269-8811, Pages:717-748

Goodwin GM, Haddad PM, Ferrier IN, et al., 2016, Evidence-based guidelines for treating bipolar disorder: Revised third edition recommendations from the British Association for Psychopharmacology, Journal of Psychopharmacology, Vol:30, ISSN:0269-8811, Pages:495-553

More Publications